Neuropeptides are systematically encountered in local interneurons, but their functional contribution in neural networks is poorly documented. In the mouse main olfactory bulb (MOB), somatostatin is mainly concentrated in local GABAergic interneurons restricted to the external plexiform layer (EPL). Immunohistochemical experiments revealed that the sst2 receptor, the major somatostatin receptor subtype in the telencephalon, is expressed by mitral cells, the MOB principal cells. As odor-activated mitral cells synchronize and generate gamma oscillations of the local field potentials, we investigated whether pharmacological manipulations of sst2 receptors could influence these oscillations in freely behaving mice. In wild-type, but not in sst2 knock-out mice, gamma oscillation power decreased lastingly after intrabulbar injection of an sst2-selective antagonist (BIM-23627), while sst2-selective agonists (octreotide and L-779976) durably increased it. Sst2-mediated oscillation changes were correlated with modifications of the dendrodendritic synaptic transmission between mitral and granule cells. Finally, bilateral injections of BIM-23627 and octreotide respectively decreased and increased odor discrimination performances. Together, these results suggest that endogenous somatostatin, presumably released from EPL interneurons, affects gamma oscillations through the dendrodendritic reciprocal synapse and contributes to olfactory processing. This provides the first direct correlation between synaptic, oscillatory, and perceptual effects induced by an intrinsic neuromodulator.
Introduction
Since the pioneer work of Adrian (1942) , gamma oscillations (40 -100 Hz) of the local field potentials (LFP) have attracted much interest in the main olfactory bulb (MOB). Disruption of these oscillations in knock-out mice alters odor discrimination (Nusser et al., 2001) . Conversely, gamma oscillations are increased when rats perform a fine odor discrimination task (Beshel et al., 2007) . Induced by odorants, these LFP oscillations are intrinsic to the MOB (Neville and Haberly, 2003) . Experimental and computational studies have underlined the key role of reciprocal dendrodendritic interactions between mitral cells and local interneurons in their generation (Lledo and Lagier, 2006; Kay et al., 2009 ). This excitatory-inhibitory microcircuit mediates recurrent and lateral inhibition, which in turn synchronizes neural activity and results in fast oscillations of the LFP. This emergent property of the olfactory network is thought to shape odorant receptive fields and to control the precise firing of the principal neurons for downstream reading (Lledo and Lagier, 2006; Kay et al., 2009) .
The MOB receives extrinsic neuromodulatory inputs that affect these oscillatory dynamics and consequently olfactory processing. In vitro, cholinergic transmission excites mitral cells and inhibits granule cells (Castillo et al., 1999; Ghatpande and Gelperin, 2009) . In vivo pharmacological blockade of cholinergic tone is associated with changes in gamma oscillations (Tsuno et al., 2008) , odor receptive fields of mitral cells, and olfactory behavior (Chaudhury et al., 2009) . Similarly, application of noradrenergic agonists excites mitral cells and enhances gamma oscillations (Gire and Schoppa, 2008) , whereas inhibition of noradrenergic receptors impairs olfactory perception and memory (Mandairon et al., 2008) . Beside these extrinsic neuromodulatory processes that involve long-range centrifugal fibers, little is known about the intrinsic regulation of network oscillations by endogenous components of the olfactory circuitry. Neuropeptides, present in local interneurons and released after highfrequency stimulations (Vezzani and Hoyer, 1999; Baraban and Tallent, 2004) , could act as intrinsic network modulators. In mice, the neuropeptide somatostatin is concentrated in a subset of external plexiform layer (EPL) interneurons (Lepousez et al., 2010) . These interneurons receive high-frequency inputs from mitral cells (Hamilton et al., 2005) , which provide a favorable context for peptide release. So far, somatostatin effects on network oscillations have been observed in the hippocampus and the thalamus, and may result from a modulation of membrane conductance and synaptic properties (Olias et al., 2004; Viollet et al., 2008) .
In the present work, after demonstrating that mitral cells express the somatostatin receptor 2 (sst2), we performed local injections of sst2-selective ligands in wild-type and sst2 knock-out mice, to evaluate in vivo how these receptors affect gamma oscillations. We then investigated sst2-mediated modulation of the dendrodendritic synaptic transmission and olfactory discrimination performances.
Materials and Methods
Animals. Two-to five-month-old sst2 knock-out mice, their wild-type littermates (backcrossed to the C57BL/6J background for 12 generations) (Zheng et al., 1997) , and C57BL/6J mice (Janvier) were housed individually on a 12 h light/dark cycle with ad libitum access to food and water. All procedures were approved by a local ethical committee, in accordance with the European Communities Council Directive (86/609/EU).
Quantitative RT-PCR. Olfactory bulb total RNA was extracted and reverse transcribed (0.5 g). Real-time qPCR was performed with an ABI Prism 7000 Sequence Detection System (Applied Biosystems). Amplification was performed using Taqman Universal Master Mix kit for sst2A (Mm03015782-S1), sst2B (Mm00436685-g1), and 18S rRNA as internal control (see supplemental Methods, available at www.jneurosci.org as supplemental material).
Stereotaxic injections. Under ketamine/xylazine anesthesia (100/10 mg/kg, i.p.), 0.25 l of octreotide (0.5 mM, Novartis) or saline (0.9% NaCl) were injected through a glass micropipette (0.1 l/min), positioned into the medial EPL (stereotaxic coordinates: AP, ϩ5.1 from bregma; ML, ϩ0.4; DV, ϩ1.5 from brain surface). Animals recovered for 30 min, then were deeply anesthetized and transcardially perfused with Zamboni fixative (4% paraformaldehyde, 0.2% picric acid in 0.1 M phosphate buffer). Brains were quickly removed, cryoprotected in 30% sucrose for 24 h, frozen in ice-cold isopentane, and stored (Ϫ80°C). For dextran-FITC injection (FD70S, Sigma; 7% diluted in 0.9% NaCl), anesthetized animals were first injected with 0.1 l of tracer in the medial glomerular layer (AP, ϩ5.1; ML, ϩ0.1; DV, ϩ1.5), recovered for 7 h, were injected with octreotide, and were perfused 1 h later.
Immunohistochemistry. Immunofluorescence labeling was performed using a characterized rabbit sst2A antiserum (Csaba et al., 2007) . The signal was revealed using biotin-streptavidin CY3 complex (Fig. 1A,B) or amplified using the tyramide amplification system (Fig. 1C-K ) (see supplemental Methods, available at www.jneurosci.org as supplemental material).
In vivo LFP recordings. Oscillatory and evoked LFPs were recorded in the EPL using a bipolar electrode (0.2-0.5 M⍀; reference electrodes to the skull) closely linked to a cannula. For lateral olfactory tract (LOT) stimulation, paired square current pulses (interstimulus interval: 30 ms) were applied every 50 s with a similar electrode inserted in the LOT. Signals were amplified and sampled using a 1401 acquisition interface and Spike2 software (CED). During the recordings, mice remained in their home cage and showed active exploration with intense sniffing activity. Signals were continuously recorded from 40 min before to 120 min after intrabulbar injection of 0.4 l of BIM-23627 (2 mM, Biomeasures), octreotide (2 mM), L-779976 (2 mM, Merck Research Laboratories), or vehicle (0.9% NaCl). Doses were chosen based on previous reports (Bassant et al., 2005; Gastambide et al., 2009) . Each mouse received the three compounds at 3 d intervals, in a random order. The fast Fourier transform algorithm was used to measure the absolute spectral power and the mean frequency of gamma (40 -100 Hz), beta (15-40 Hz), and theta (2-12 Hz) bands. Absolute values were normalized to the total power of the spectrum and to the mean basal value (set at 1). For LOT-evoked LFPs, measured peak amplitudes were normalized to baseline and to the mean basal value (set at 1) (see supplemental Methods, available at www. jneurosci.org as supplemental material).
Odor discrimination task. Mice were first implanted with two cannulae on top of the MOB. One week after surgery, they were trained using an operant conditioning go/no-go procedure in home-made computercontrolled olfactometers. In this paradigm, the presence of the positive odor stimulus (Sϩ) was associated with a water reward obtained by licking a water delivery tube. For the negative odor stimulus (SϪ), mice received no water reward and had to refrain from licking. In each trial, a single stimulus (Sϩ or SϪ) was presented, and the percentage of correct responses was determined for each block of 20 trials. All mice underwent a session of 10 blocks per day. Once mice reached 85% of correct responses, daily sessions were preceded by a bilateral injection of 1 l of BIM-23627 (2 mM), octreotide (2 mM), or vehicle (mean injection delay before performing the task: 37 Ϯ 1 min). Olfactory discrimination performances were determined with monomolecular odor compounds and binary odor mixtures (Sigma) (see supplemental Methods, available at www.jneurosci.org as supplemental material).
Results

Mitral cells express the sst2 receptor
In mice olfactory bulb, the sst2 receptor subtype exists as two splice variants: sst2A, the major full-length form, predominates over sst2B, the minor C terminus spliced form (sst2A/sst2B mRNA ratio: 32.7 Ϯ 1.3; n ϭ 3). In rodent brain, sst2A receptors are targeted to the plasma membrane on somatodendritic processes resulting in a diffuse sst2A immunolabeling, but in vivo agonist stimulation induces rapid (in the order of minutes) internalization and clustering of receptors into the soma (Csaba et al., 2007) . Thirty minutes after octreotide injection in the medial EPL ( Fig. 1 A) , sst2A receptor immunoreactivity was concentrated in large cell bodies (ϳ20 m diameter) in the mitral cell layer (MCL) (Fig. 1 B) and in large dendrites (ϳ1 m diameter) perpendicular to the layer ( Fig. 1 B, inset) . The laminar distribu- tion of immunopositive cells in the MCL and their size suggest that sst2A-immunoreactive profiles correspond to mitral cells. To confirm this, agonist-induced internalization of sst2A receptors was examined in mitral cell bodies identified after tracer injection. Dextran-FITC injection in the glomerular layer (GL) anterogradely labeled several characteristic mitral cells (Fig. 1C,F,I , arrowheads) and a few MCL interneurons (Fig. 1F, open arrowheads) . One hour after agonist injection, sst2A labeling was even more concentrated in large cell bodies in the MCL (Fig. 1D,G,J) . Tracer-positive mitral cells were systematically immunopositive for sst2A (Fig. 1E ,H,K, arrowheads), whereas tracer-positive interneurons were immunonegative ( Fig. 1 H, open arrowheads) .
Local injections of sst2-selective agonists and antagonist influence gamma oscillation power and dendrodendritic interaction in freely behaving mice Activated assemblies of mitral cells typically engage in rhythmic synchronization in the gamma-frequency range (Lledo and Lagier, 2006; Kay et al., 2009 ). Because of sst2A receptor localization in mitral cells, we hypothesized that endogenous somatostatin influences mitral cell properties and thus gamma oscillations. To test this, local injections of sst2-selective agonists and antagonist were coupled to LFP recordings in the MOB of awake mice during spontaneous exploratory activity. Typical olfactory LFP activity was composed of bursts of gamma oscillations (40 -100 Hz), superimposed onto theta waves (6 -9 Hz) associated with sniffing activity (Fig. 2 A 1 ,A 2 ) . A decrease in gamma power appeared 30 min after injection of BIM-23627, an sst2-selective antagonist, and lasted up to 120 min (F (16,576) ϭ 7.53, p Ͻ 0.0001) (Fig.  2 A 1 ,A 2 ,B 1 ,B 2 ) . Conversely, injection of octreotide, an sst2-selective agonist, induced a delayed and long-lasting increase of gamma power (F (16,576) ϭ 4.34, p Ͻ 0.0001) (Fig. 2 B 1 ,B 2 ). Yet these effects did not reflect a global change of the whole spectral power. In the 40 -70 min window after sst2-antagonist injection (Fig. 2B 2 , "post" time block) , the relative power of the gamma band, normalized to the total spectral power, still significantly decreased by unpaired t test, p Ͻ 0.05. B 2 , Comparison of the relative gamma power between "pre" (referring to the Ϫ40/Ϫ10 min) and "post" (referring to the ϩ40/ϩ70 min) time blocks (normalized to the total spectral power with "pre" block set at 1) for saline (white, n ϭ 18), BIM-23627 (black, n ϭ 20), octreotide (gray, n ϭ 20), and L-779976 (light gray, n ϭ 16). Paired t test, **p Ͻ 0.01, ***p Ͻ 0.001. C, Relative gamma power between "pre" and "post" time blocks (normalized to the total spectral power) in wild-type (left part, n ϭ 8) and sst2 knock-out(rightpart,nϭ8)animals.D 1 ,Evolutionofthepeakamplitudeoftheconditioningresponse(blackcircle)andthetestresponse(blacksquare)from40minbeforeto120minafterBIM-23627injection (n ϭ 10). D 2 , "Conditioning" (open arrowhead) and "test" (arrowhead) field potential responses in the EPL after LOT stimulation (arrow), before (solid line) and after (dashed line) BIM-23627 injection. D 3 , Paired-pulse ratio change between "pre" and "post" time blocks. **Paired t test, p Ͻ 0.01. Error bars indicate SEM.
Ϫ33.6 Ϯ 6.8% in BIM-23627-injected mice (t (19) ϭ 4.93, p Ͻ 0.0001) compared to "pre" time block, while octreotide-injected mice displayed an increase of ϩ36.2 Ϯ 11.4% (t (19) ϭ 3.18, p ϭ 0.005). A similar effect was observed with L-779976, another sst2-selective agonist (Fig. 2B 2 ) (ϩ62.8 Ϯ 15.6%, t (15) ϭ 4.01, p ϭ 0.001).
Drug treatments did not affect gamma frequency (Fig. 2 B 1 , inset) (frequency changes between "pre" and "post" blocks: Ϫ0.8 Ϯ 0.3 Hz, Ϫ0.8 Ϯ 0.4 Hz, and Ϫ1.4 Ϯ 0.5 Hz respectively for saline, BIM-23627 and octreotide, p Ͼ 0.1). Power changes were specific to the gamma frequency band, as beta and theta oscillation powers remained unaffected (relative power changes between "pre" and "post" blocks, respectively for saline, BIM-23627 and octreotide: for beta oscillations, Ϫ8.8 Ϯ 4.6%, Ϫ7.7 Ϯ 3.6%, and Ϫ0.1 Ϯ 3.3%, p Ͼ 0.05; for theta oscillations, Ϫ6.1 Ϯ 9.8%, Ϫ14.4 Ϯ 7.1%, Ϫ7.2 Ϯ 6.0%, p Ͼ 0.05). The phase relationship of gamma bursts with the sniff cycle, measured from autocorrelograms between gamma oscillation amplitude and theta rhythm, was not affected by drug injections (data not shown). In contrast to wild-type mice, gamma power was not affected by drug injection in sst2 knock-out animals (Fig. 2C) . Moreover, knock-out mice displayed a pronounced decrease in gamma power compared to wild-type animals (Ϫ30.3 Ϯ 3.4%, t (15) ϭ 3.01, p ϭ 0.009), without significant changes in the other frequency bands (data not shown).
Dendrodendritic synaptic interactions between mitral and granule cells support gamma oscillations (Lledo and Lagier, 2006; Kay et al., 2009 ). Sst2-mediated modulation of dendrodendritic synaptic transmission was investigated by recording LOT-evoked LFPs after paired stimulations. Typical evoked LFPs were composed of a pair of large negativity evoked by the first ("conditioning" response) and the second ("test" response) LOT stimulations ( Fig. 2 D 2 ). This negativity reflects the activity of the mitral-togranule cell dendrodendritic excitatory synapses, and the diminution of amplitude of the "test" response reflects the level of inhibition in mitral cell evoked by the first "conditioning" stimulation (Mori and Takagi, 1978; Tsuno et al., 2008) . BIM-23627 injection induced a delayed (ϳ30 min) and long-lasting increase of the "conditioning" response ( Fig. 2 D 1 ) (ϩ8.2 Ϯ 2.4%, t (9) ϭ 3.37, p ϭ 0.008) and decrease of the "test" response (Ϫ26.6 Ϯ 8.3%, t (9) ϭ 3.17, p ϭ 0.011), which resulted in a general decrease of the paired-pulse ratio (Fig. 2 D 3 ) (Ϫ31.1 Ϯ 7.9%, t (9) ϭ 3.92, p ϭ 0.003).
Odor discrimination performances are modified after intrabulbar injection of sst2-selective agonist and antagonist
Mice were trained to sample a pair of odorants and to lick only in response to the rewarded odorant. One day after reaching the performance criterion with a pair of enantiomers [1% (ϩ)-carvone vs 1% (Ϫ)-carvone], the same task was preceded by bilateral injections of BIM-23627, octreotide, or saline. Injections were done 37 Ϯ 1 min before the task, to take into account the 30 -40 min delayed effects of the drugs on gamma power. Regardless of their treatment, mice discriminated the two odorants with maximal accuracy (Fig. 3) . Then, mice had to discriminate between progressively more and more similar binary mixtures of carvone enantiomers, so that the difficulty of the olfactory discrimination task increased over sessions. Whereas octreotideand vehicle-injected mice succeeded in discriminating the 60/40 mixture, BIM-23627-injected mice failed to reach the performance criterion [F (9,108) ϭ 2.37, p ϭ 0.017 (Fig. 3A) ; t (12) ϭ 2.2, p ϭ 0.048 (Fig. 3B) ]. With the 55/45 mixture, octreotide-injected mice performed significantly better than controls (F (9,90) ϭ 2.12, p ϭ 0.035; t (12) ϭ 2.35, p ϭ 0.036) (Fig. 3B) . A new pair of monomolecular odorants [1% (ϩ)-limonene vs 1% (Ϫ)-limonene] was then tested to examine if drug treatments interfered with the acquisition of a novel odor-reward association. All drug-treated animals performed limonene enantiomer discrimination as well as controls. Mice were then asked to discriminate between pro- Table S1 , available at www.jneurosci.org as supplemental material) and the injection status are indicated below (Cϩ/CϪ and Lϩ/LϪ, respectively, for carvone and limonene enantiomers). Repeated-measure ANOVA, saline versus BIM-23627, ᭛ p Ͻ 0.05, ᭛᭛ p Ͻ 0.01. B, Average accuracy for the last three training blocks (saline, white circles, n ϭ 7; BIM-23627, black squares, n ϭ 8, octreotide gray squares, n ϭ 7). The odor pair, the odorant relative concentration, and the injection status are indicated below. Unpaired t test, drug versus saline, # p Ͻ 0.05, ## p Ͻ 0.01. Error bars indicate SEM.
gressively more and more similar binary mixtures of limonene enantiomers. Compared to saline, BIM-23627 impaired odor discrimination with the 80/20 [F (9,108) ϭ 3.13, p ϭ 0.0022 (Fig.  3A) ; t (12) ϭ 3.34, p ϭ 0.0059) (Fig. 3B) ] and the 60/40 [F (9,108) ϭ 2.76, p ϭ 0.0063 (Fig. 3A) ; t (11) ϭ 3.54; p ϭ 0.0046 ( Fig. 3B) ] mixtures. Conversely, octreotide-injected mice performed better than controls with the 57.5/42.5 mixture (F (9,99) ϭ 3.01, p ϭ 0.0033; t (11) ϭ 2.16, p ϭ 0.056) (Fig. 3B ).
Discussion
In this study, we examined how the neuropeptide somatostatin influences olfactory processing. Mitral cell dendrites were identified as an action site of the peptide as they express sst2A, the full-length form of the sst2 receptor. The selective blockade of sst2 receptors enhanced dendrodendritic inhibition of mitral cell dendrites, decreased gamma oscillation power while sparing other frequency bands, and impaired odor discrimination. Conversely, sst2-selective agonists increased gamma oscillation power, and improved discrimination performances. Thus, endogenous release of somatostatin strongly influences gamma oscillation homeostasis, through the modulation of dendrodendritic synaptic properties, and contributes to olfactory processing.
Somatostatin tone on mitral cell sst2 receptors in the MOB
Among the five somatostatin receptor subtypes, sst2, sst3, and sst4 are present in the MOB (Videau et al., 2003) . The known pharmacological selectivity of the three agents used herein and the absence of drug effects in sst2 knock-out animals suggest that the observed effects are essentially mediated by sst2 receptors. The reduced gamma power, after pharmacological blockade or genetic deletion of sst2 receptors, reveals the existence of a potent endogenous somatostatin tone on these receptors that may participate in the homeostasis of the reciprocal synapse by regulating synaptic transmission in mitral cells. In the MOB, sst2 receptors are mostly concentrated in the EPL and somatostatin is present in a subset of EPL interneurons (Lepousez et al., 2010) that receive high-frequency inputs from mitral cells (Hamilton et al., 2005) . By analogy with hippocampal somatostatin-expressing cells during seizure (Vezzani and Hoyer, 1999; Baraban and Tallent, 2004) , an elevated level of excitation of somatostatin interneurons induced by mitral cells may control peptide release that, in turn, would modulate the strength of the dendrodendritic synapse.
Delayed and long-lasting effects on gamma oscillations and dendrodendritic inhibition
In awake animals, changes in fast oscillations in the gamma range do not likely result from a variation of firing rate of individual neurons but rather reflect a dynamical state of mitral cell population firing patterns (Rinberg and Gelperin, 2006) . Indeed, when animals perform correctly a discrimination task, gamma oscillations are enhanced (Beshel et al., 2007) , whereas mitral cell responses are hardly detectable by measuring single-cell firing rate (Kay and Laurent, 1999; Doucette and Restrepo, 2008) . Although the dendrodendritic synapse is essential for gamma oscillation generation, the physiological mechanisms underlying these oscillations are not well understood. Recent studies suggest that these oscillatory dynamics result from the interaction between the dendrodendritic synaptic transmission and intrinsic properties of both cell partners, such as subthreshold oscillations and spiking activity (Lledo and Lagier, 2006; Kay et al., 2009 ). Herein, we observed that gamma oscillation reduction after sst2 receptor blockade is associated with an increase of dendrodendritic inhibition. Changes in the decay time but not in the amplitude of dendrodendritic inhibition tune the frequency of gamma oscillations (Lagier et al., 2007) . Thus, the lack of sst2-mediated changes in oscillation frequency suggests that sst2 receptors modulate the amplitude but not the kinetics of inhibition. As sst2 receptors are localized in mitral cell dendrites, sst2 activation could decrease mitral-to-granule cell glutamate release and consequently decrease GABA release from granule cells. Indeed, the increase of the conditioning response observed after blocking sst2 receptors supports an increase excitatory drive on granule cells that, in turn, could activate inhibitory synaptic transmission, as reported for acetylcholine (Ghatpande and Gelperin, 2009) . In other brain regions, presynaptic modulation of glutamate release by sst2 receptors results from the inhibition of voltage-gated calcium channels (VGCC) or from the activation of specific potassium channels such as A-type channels (I A ) (Baraban and Tallent, 2004; Viollet et al., 2008) . In mitral cells, VGCC and I A contribute to glutamate release (Lledo and Lagier, 2006) , but whether they constitute potential effectors of sst2 receptors remains to be tested. Alternatively, the decreased inhibition on mitral cells after sst2 receptor activation could originate from a postsynaptic control of granule-to-mitral inhibitory transmission, as observed for dopamine (Brünig et al., 1999) . In this latter study, a delayed and gradual upmodulation of GABA A receptors occurred in mitral cells after D 2 receptor activation through PKC-induced phosphorylation. Here, sst2-selective agonists and antagonist specifically affected gamma oscillations after 30 min. This interval does not correspond to a diffusion delay, since injection of a chloride channel blocker affects LFP signal 5 min after injection (G. Lepousez, personal communication) . Therefore, the delayed and long-lasting effects observed with somatostatin-related agents may develop slowly and durably, resulting from complex or indirect transduction pathways, the nature of which remains to be characterized. Similar delayed and long-lasting effects on gamma oscillations have already been observed in the MOB after noradrenergic agonist applications (Gire and Schoppa, 2008) , and after cholinergic activation in the visual cortex (Rodriguez et al., 2004) .
A novel correlate between dendrodendritic transmission, network oscillations, and fine odor discrimination By increasing dendrodendritic inhibition, sst2-antagonist injection dramatically reduced gamma oscillation power, and significantly decreased odor discrimination of odor mixtures but not of monomolecular odorants. Conversely, sst2-agonists increased both gamma power and odor discrimination abilities. First, these results confirm the importance of the dendrodendritic reciprocal synapse in gamma oscillation generation. Herein, we observed that in awake mice, the increase of dendrodendritic inhibition after sst2 receptor blockade is associated with a reduction of gamma oscillation power. This contrasts with in vitro experiments in which a positive relationship between dendrodendritic inhibition amplitude and oscillation power has been reported (for review, see Lledo and Lagier, 2006) . In vivo, somatostatin modulation of dendrodendritic inhibition may control the extent of action potential backpropagation in mitral cell dendrites (Xiong and Chen, 2002) , thereby controlling the extent of lateral inhibition, and the level of synchrony and oscillations in the network. Interestingly, after noradrenaline application, a long-term increase in gamma power is also observed (Gire and Schoppa, 2008) and is thought to result from mitral cell disinhibition (Jahr and Nicoll, 1982) . Second, our data confirm the importance of fast oscillatory population dynamics for the discrimination of highly similar stimuli, and the role of synchronization in pattern segmentation (Lledo and Lagier, 2006; Kay et al., 2009) . Changes occurred in the gamma but not in the beta bands. LFP recording conditions (spontaneous activity) might have underestimated beta oscillation power, which is enhanced with learning (Ravel et al., 2003) . Nevertheless, injections of sst2-ligands did not interfere with the acquisition of a novel odor-reward association, suggesting that beta oscillations, which are essential for a such association (Kiselycznyk et al., 2006) , remained unaffected. Somatostatin is involved in cognitive processes, and interestingly its concentration is decreased in several brain disorders associated with cognitive impairments ). The present data suggest that disturbance of endogenous levels of somatostatin impairs neural synchronization and consequently affects behavioral responses. Future research is needed to correlate intrinsic levels of somatostatin with pathological EEG modifications and cognitive deficits observed in brain disorders.
